https://www.medpagetoday.com/infectiousdisease/hepatitis/73368 Highest among commercial insurers, increased over study period More than a third of chronic hepatitis C (HCV) patients were denied access to direct-acting antiviral (DAA) treatment by their insurance provider, researchers found. Among patients prescribed DAAs, 35.5% (95% CI 34.5%-36.5%) had their prescriptions denied by their insurer, reported Charitha Gowda, MD, of Ohio State […]
Filed under: General Problems | Leave a Comment »